Finalization of share buyback program in Initiator Pharma

Initiator Pharma A/S (“Initiator” or the “Company”) has today finalized the share buyback that was announced on 21 June 2023.

Today the Initiator has finalized the buyback of shares that was announced on 21 June, 2023. In connection with the buy back, the Company has bought a total of 19,500 shares (“Treasury Shares”) at an average price of 7,24.

Initiator has sold the Treasury Shares to certain members of the Board of Directors under the LTI2022-program. Each share was sold at a price of DKK 0.105 per share corresponding to par value.

The aggregate gross proceeds from the sale of treasury shares are DKK 2,047.50.